comparemela.com

Page 9 - சனோஃபி கிளாக்சோஸ்மித்க்லைன் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

The First COVID-19 Vaccine Is Here Is It Safe for People With HIV?

The First COVID-19 Vaccine Is Here. Is It Safe for People With HIV? Advertisement The First COVID-19 Vaccine Is Here. Is It Safe for People With HIV? Experts encourage HIV-positive people to get the coronavirus vaccine and say there’s no reason to think it won’t be safe. Advertisement On December 11, the Food and Drug Administration (FDA) granted emergency use authorization for the first COVID-19 vaccine in the United States, after an expert advisory panel voted overwhelmingly that its benefits of outweigh the risks. That vaccine, from Pfizer and BioNTech, is currently being rolled out nationwide. A second vaccine, from Moderna and the National Institutes of Health, is expected to receive authorization within days.

UK to Spend 3 7 Billion Pounds on Vaccines and Will Take Liability for Claims - Novinite com

Britain has agreed to spend 3.7 billion pounds on Covid-19 vaccines and in most cases will bear the liability if claims are made against the pharmaceutical companies involved. The British government has agreed supply deals for 357 million doses of seven different candidate shots, but has not gone into detail about how much it has spent or indemnity agreements, citing commercial confidentiality around the contracts. The government had signed firm deals for five of the candidates, including the Pfizer/BioNTech shot which has already been approved and is being rolled out, as well as those developed by Oxford/AstraZeneca, France’s Valneva, Novavax and Moderna.

Britain to spend US$5 bil on vaccines and bear full liability for claims

Britain to spend US$5 bil on vaccines and bear full liability for claims
freemalaysiatoday.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from freemalaysiatoday.com Daily Mail and Mail on Sunday newspapers.

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.